Join us from June 22 to 25 at one of the world’s leading events for the biotechnology and life sciences industry. The BIO International Convention offers privileged access to a rapidly expanding global innovation ecosystem, with a strong focus on key sectors such as cell and gene therapies, personalized medicine, biomanufacturing, artificial intelligence applied to healthcare, oncology, and rare diseases. Wallonia stands out as one of the largest foreign delegations—now is the time to get acquainted.
Organized by the Biotechnology Innovation Organization (BIO), the 2026 edition will take place in San Diego and will bring together leaders from biotechnology companies, international investors, policymakers, researchers, and industry partners from over 60 countries.
With approximately 20,000 participants, the convention is a benchmark platform for investment, business development, and licensing across biotechnology, pharmaceuticals, and innovative healthcare. The program spans the entire value chain, from preclinical research to market access, with a strong emphasis on investment opportunities and strategic partnerships.
A key highlight of the event, the BIO Partnering™ platform enables thousands of targeted B2B meetings, fostering discussions between startups, large corporations, investment funds, and institutional stakeholders. The BIO International Convention is therefore a strategic venue to identify investment opportunities, assess emerging technologies, and build impactful international partnerships.
Come and meet our Walloon companies.
Linked articles
Related articles
The duo behind Trasis: science, strategy, and a shared vision
Telix signs agreement with IBA for four Cyclone® KIUBE cyclotrons to accelerate radiopharmaceutical production in the United States
15 Companies Not to Miss at the LSX World Congress in Lisbon
